Article Text

Download PDFPDF
Magnetic Resonance Imaging in Gynecological Oncology
  1. Vanessa N. Harry*,
  2. Heather Deans,
  3. Emma Ramage,
  4. David E. Parkin* and
  5. Fiona J. Gilbert
  1. * Departments of Gynaecological Oncology and
  2. Radiology, Aberdeen Royal Infirmary; and
  3. Department of Radiology, University of Aberdeen, United Kingdom.
  1. Address correspondence and reprint requests to Vanessa N. Harry, Ward 43, Department of Gynaecological Oncology, Aberdeen Royal Infirmary, Foresterhill, Aberdeen, AB25 2ZN, United Kingdom; E-mail: v.harry{at}abdn.ac.uk.

Abstract

Magnetic resonance imaging (MRI) has become an indispensable tool in the assessment of malignant disease. With increasingly sophisticated systems and technical advancements, MRI has continued to expand its role in providing crucial information regarding cancer diagnosis and management. In gynecological malignancies, this modality has assumed greater responsibility, particularly in the evaluation of cervical and endometrial cancers. In addition to conventional imaging, innovative techniques such as dynamic contrast-enhanced MRI and diffusion-weighted MRI show promise in offering early assessment of tumor response. This paper reviews the current role of MRI in gynecological cancers and highlights the potential of novel techniques in improving patient care.

  • MRI
  • Cervical cancer
  • Endometrial cancer
  • Ovarian cancer

Statistics from Altmetric.com

Footnotes

  • Financial support/Disclaimer/Conflict of interest: None

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.